Loading...
NASDAQ: INMD
InMode Ltd.
Healthcare · Medical - Devices
Market Cap
$873.72M
52w High
$19.09
52w Low
$12.72
P/E
9.31
Volume
947.32K
Outstanding Shares
63.36M
Company profile
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally.
CEOMoshe Mizrahy
SectorHealthcare
IndustryMedical - Devices
Employees599
IPO dateAug 8, 2019
Valuation
Forward P/E—
EV/EBITDA5.95
Enterprise value$660.15M
Stock splits
Oct 1, 20212:1
Profitability & growth
Revenue growth6.13%
Gross margin78.54%▼2.21%vs FY2024
Operating margin23.05%▼19.14%vs FY2024
ROE13.73%▼46.68%vs FY2024
Analyst consensus
RatingBuy
Target price$16.00▲16.03%
6
Buy
5
Hold
0
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 27, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$0.47
$0.43
Q3FY25
ActualEst.
$0.38
$0.35
Q4FY25
ActualEst.
$0.46
$0.42
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$95.6M
$98.45M
Q3FY25
ActualEst.
$93.17M
$90.94M
Q4FY25
ActualEst.
$103.85M
$101.49M
Q1FY26
Next Est.
—